Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 151,021Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Dr. Reddy's Laboratories

02 1Intas Pharmaceuticals

03 1Lotus Pharmaceutical

04 1Lupin Ltd

05 6Novartis Pharmaceuticals Australia Pty Limited

06 2Novartis Pharmaceuticals Corporation

07 1Novartis South Africa (Pty) Ltd

08 1Teva Pharmaceutical Industries

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : RX

Registration Country : USA

MIDOSTAURIN

Brand Name : MIDOSTAURIN

Dosage Form : CAPSULE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2024-06-28

Application Number : 215921

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Lead Market Dossiers- Filed

Registration Country : India

Midostaurin

Brand Name :

Dosage Form : Oral Solid Dosage Form

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Lead Market Dossiers- Filed

Registration Country : India

Dr Reddy Company Banner

03

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Midostaurin

Brand Name :

Dosage Form : Soft Gelatin Capsule

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

04

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

MIDOSTAURIN

Brand Name : MIDOSTAURIN

Dosage Form : CAPSULE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number : 215834

Regulatory Info :

Registration Country : USA

blank

05

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

MIDOSTAURIN

Brand Name : MIDOSTAURIN

Dosage Form : CAPSULE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2024-05-10

Application Number : 216015

Regulatory Info : RX

Registration Country : USA

blank

06

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

MIDOSTAURIN

Brand Name : RYDAPT

Dosage Form : CAPSULE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2017-04-28

Application Number : 207997

Regulatory Info : RX

Registration Country : USA

blank

07

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

MIDOSTAURIN

Brand Name : RYDAPT

Dosage Form : CAPSULE

Dosage Strength : 25MG

Packaging : 56/112

Approval Date :

Application Number : 2466236

Regulatory Info : Prescription

Registration Country : Canada

blank

08

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

MIDOSTAURIN

Brand Name : MIDOSTAURIN

Dosage Form : CAPSULE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2024-04-29

Application Number : 216076

Regulatory Info : RX

Registration Country : USA

blank

09

Novartis South Africa (Pty) Ltd

Country
Fi Europe 2024
Not Confirmed
arrow

Novartis South Africa (Pty) Ltd

Country
arrow
Fi Europe 2024
Not Confirmed

Midostaurin

Brand Name : Sotauric 25mg

Dosage Form : CAP

Dosage Strength : 25mg

Packaging : 56X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

10

Novartis Pharmaceuticals Australia ...

Country
Fi Europe 2024
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
Fi Europe 2024
Not Confirmed

midostaurin

Brand Name : Rydapt

Dosage Form :

Dosage Strength :

Packaging : 112

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

11

Novartis Pharmaceuticals Australia ...

Country
Fi Europe 2024
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
Fi Europe 2024
Not Confirmed

midostaurin

Brand Name : Rydapt

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

12

Novartis Pharmaceuticals Australia ...

Country
Fi Europe 2024
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
Fi Europe 2024
Not Confirmed

midostaurin

Brand Name : Rydapt

Dosage Form :

Dosage Strength :

Packaging : 112

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

13

Novartis Pharmaceuticals Australia ...

Country
Fi Europe 2024
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
Fi Europe 2024
Not Confirmed

midostaurin

Brand Name : Rydapt

Dosage Form :

Dosage Strength :

Packaging : 112

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

14

Novartis Pharmaceuticals Australia ...

Country
Fi Europe 2024
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
Fi Europe 2024
Not Confirmed

midostaurin

Brand Name : Rydapt

Dosage Form :

Dosage Strength :

Packaging : 112

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

15

Novartis Pharmaceuticals Australia ...

Country
Fi Europe 2024
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
Fi Europe 2024
Not Confirmed

midostaurin

Brand Name : Rydapt

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank